Nanoprobe-based molecular imaging for tumor stratification-Reference-Cited by-同舟云学术

Nanoprobe-based molecular imaging for tumor stratification

Published:2023 Issue:18 Volume:52 Page:6447-6496
ISSN:0306-0012
Container-title:Chemical Society Reviews
language:en
Short-container-title:Chem. Soc. Rev.

Author:

Ma Xianbin¹,Mao Mingchuan¹,He Jiaqi²,Liang Chao²,Xie Hai-Yan³^ORCID

Affiliation:

1. School of Medical Technology, Beijing Institute of Technology, Beijing 100081, P. R. China

2. School of Life Science, Beijing Institute of Technology, Beijing 100081, P. R. China

3. State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Chemical Biology Center, Peking University, Beijing, 100191, P. R. China

Abstract

This review highlights the use of nanoprobes to stratify various therapeutic modalities and provides an outlook on the challenges and future directions of nanoprobes for patient stratification.

Funder

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2023/CS/D3CS00063J

Reference379 articles.

1. Whole-tissue biopsy phenotyping of three-dimensional tumours reveals patterns of cancer heterogeneity

2. To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?

3. Toward understanding and exploiting tumor heterogeneity